These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 19499715)

  • 1. [Levofloxacin (Tavanic) in complex therapy of tuberculosis].
    Sokolova GB; Kunichan AD; Lazareva IaV
    Antibiot Khimioter; 2009; 54(1-2):31-7. PubMed ID: 19499715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens.
    Yew WW; Chan CK; Chau CH; Tam CM; Leung CC; Wong PC; Lee J
    Chest; 2000 Mar; 117(3):744-51. PubMed ID: 10713001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Floracide, a Russian 3rd generation fluoroquinolone in complex therapy of tuberculosis].
    Sokolova GB; Kirtaeva OV; Lazareva IaV; Tsybanev AA
    Antibiot Khimioter; 2008; 53(5-6):28-31. PubMed ID: 19069179
    [No Abstract]   [Full Text] [Related]  

  • 4. [Efficacy of ofloxacin (zanocin) in the treatment of multidrug resistant pulmonary tuberculosis].
    Mishin VIu; Vasil'eva IA
    Antibiot Khimioter; 2003; 48(8):7-10. PubMed ID: 14722936
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rifapex, a new antituberculosis agent].
    Sokolova GB; Krasnov VA; Reĭkhrud TA; Tsybanev AA
    Antibiot Khimioter; 2009; 54(1-2):38-41. PubMed ID: 19499716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of an intensive intermittent-induction regimen and duration of short-course treatment for human immunodeficiency virus-related pulmonary tuberculosis. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG).
    el-Sadr WM; Perlman DC; Matts JP; Nelson ET; Cohn DL; Salomon N; Olibrice M; Medard F; Chirgwin KD; Mildvan D; Jones BE; Telzak EE; Klein O; Heifets L; Hafner R
    Clin Infect Dis; 1998 May; 26(5):1148-58. PubMed ID: 9597244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An optimized background regimen design to evaluate the contribution of levofloxacin to multidrug-resistant tuberculosis treatment regimens: study protocol for a randomized controlled trial.
    Bouton TC; Phillips PPJ; Mitnick CD; Peloquin CA; Eisenach K; Patientia RF; Lecca L; Gotuzzo E; Gandhi NR; Butler D; Diacon AH; Martel B; Santillan J; Hunt KR; Vargas D; von Groote-Bidlingmaier F; Seas C; Dianis N; Moreno-Martinez A; Horsburgh CR
    Trials; 2017 Nov; 18(1):563. PubMed ID: 29178937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of tuberculosis with levofloxacin or moxifloxacin: report of 6 pediatric cases.
    Chauny JV; Lorrot M; Prot-Labarthe S; De Lauzanne A; Doit C; Géréral T; Bourdon O
    Pediatr Infect Dis J; 2012 Dec; 31(12):1309-11. PubMed ID: 22814964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of levofloxacin in a murine model of tuberculosis.
    Klemens SP; Sharpe CA; Rogge MC; Cynamon MH
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1476-9. PubMed ID: 7979275
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduced mycobacterial resistance to antituberculous drugs in the experiment and clinic: immediate and long-term results].
    Belianin II; Shmelev EI
    Probl Tuberk Bolezn Legk; 2007; (2):31-8. PubMed ID: 17419333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A controlled study of rifabutin and an uncontrolled study of ofloxacin in the retreatment of patients with pulmonary tuberculosis resistant to isoniazid, streptomycin and rifampicin. Hong Kong Chest Service/British Medical Research Council.
    Tuber Lung Dis; 1992 Feb; 73(1):59-67. PubMed ID: 1326349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case of pulmonary multi-drug resistant tuberculosis with left destroyed lung, treated with pneumonectomy].
    Koyama K; Kawakami K; Harada Y; Yamaryo T; Kimura Y
    Kekkaku; 2007 Jul; 82(7):577-81. PubMed ID: 17695788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [2 cases of drug-resistant pulmonary tuberculosis treated with ofloxacin].
    Krasucka-Kluźniak A; Krakówka P
    Pneumonol Pol; 1989 Apr; 57(4):249-52. PubMed ID: 2516906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sparfloxacin in combined therapy for pulmonary tuberculosis].
    Sokolova GB; Khaĭmenova TIu; Lazareva IaV; Khaĭmenov AIa
    Antibiot Khimioter; 2008; 53(5-6):21-7. PubMed ID: 19069178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tuberculosis drug resistance in new and previously treated pulmonary tuberculosis cases in Burkina Faso.
    Sangaré L; Diandé S; Badoum G; Dingtoumda B; Traoré AS
    Int J Tuberc Lung Dis; 2010 Nov; 14(11):1424-9. PubMed ID: 20937182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term treatment of pulmonary tuberculosis with ofloxacin in a subject with liver cirrhosis.
    Bagnato GF; Di Cesare E; Gulli S; Cucinotta D
    Monaldi Arch Chest Dis; 1995 Aug; 50(4):279-81. PubMed ID: 7550207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro activities of the newly synthesised ER-2 against clinical isolates of Mycobacterium tuberculosis susceptible or resistant to antituberculosis drugs.
    Rao SS; Raghunathan R; Ekambaram R; Raghunathan M
    Int J Antimicrob Agents; 2009 Nov; 34(5):451-3. PubMed ID: 19625168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A study on the clinical efficacy of a combination regimen with levofloxacin and capreomycin in the treatment of multi-drug resistant pulmonary tuberculosis].
    Chen QL; Chen L; Yin JJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2003 Aug; 26(8):454-7. PubMed ID: 14505519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for multidrug-resistant tuberculosis among HIV-infected patients and response to specific drug regimens. Terry Beirn Community Programs for Clinical Research on AIDS (CPCRA) and the AIDS Clinical Trials Group (ACTG), National Institutes for Health.
    Telzak EE; Chirgwin KD; Nelson ET; Matts JP; Sepkowitz KA; Benson CA; Perlman DC; El-Sadr WM
    Int J Tuberc Lung Dis; 1999 Apr; 3(4):337-43. PubMed ID: 10206505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The treatment of tuberculosis. I. Mycobacterial subpopulations in the lesions and antitubercular drugs].
    Corlan E
    Pneumoftiziologia; 1992; 41(4):231-42. PubMed ID: 1339503
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.